https://covid19advocacy.org/we-are-recruiting-act-a-facilitation-council-civil-society-representatives/2022-02-15T03:49:09+00:00https://covid19advocacy.org/act-accelerator-vaccine-pillar-covax-cso-representatives-announced/2022-01-10T19:40:27+00:00https://covid19advocacy.org/remarks-from-interim-cso-representatives-to-the-facilitation-council-of-the-act-a-november-2020/2022-01-10T19:40:39+00:00https://covid19advocacy.org/remarks-from-interim-cso-representatives-to-the-facilitation-council-of-the-act-a-february-2021/2022-01-10T19:41:28+00:00https://covid19advocacy.org/call-for-applications-cs-community-reps-to-the-act-a-health-systems-connector/2022-01-10T19:42:07+00:00https://covid19advocacy.org/nomination-process-civil-society-representatives-to-covax-amc-engagement-group-and-shareholders-council/2022-01-10T19:42:21+00:00https://covid19advocacy.org/dr-rahman-and-peter-owiti-remarks-at-5th-act-a-facilitation-council-call-for-new-collaborations-on-test-treat-and-a-transformation-and-de-colonization-of-the-vaccine-response-march-2021/2022-03-01T22:20:47+00:00https://covid19advocacy.org/community-and-civil-society-health-systems-connector-representatives-selected/2022-01-10T19:42:56+00:00https://covid19advocacy.org/covax-civil-society-representatives-statement-on-the-launch-of-the-covax-investment-opportunity-april-2021/2022-03-01T22:21:21+00:00https://covid19advocacy.org/g7-action-on-current-and-future-oxygen-crises-urged-by-c-cso-facilitation-council-representatives/2022-03-01T22:21:47+00:00https://covid19advocacy.org/act-a-facilitation-council-6th-meeting-may-2021/2022-03-01T22:22:18+00:00https://covid19advocacy.org/act-a-communities-civil-society-representatives-welcome-the-re-launch-of-the-covid-19-technology-access-pool-c-tap/2022-03-01T22:22:46+00:00https://covid19advocacy.org/nomination-process-civil-society-and-community-representatives-to-covax-manufacturing-taskforce/2022-01-10T19:44:10+00:00https://covid19advocacy.org/june-9th-antigen-rdt-letter-to-the-who/2022-03-01T22:23:17+00:00https://covid19advocacy.org/communities-and-civil-society-act-a-platform-long-term-consultancies/2022-01-10T19:44:28+00:00https://covid19advocacy.org/current-targets-and-strategies-must-be-corrected-to-respond-adequately-to-covid-19-emergency/2022-03-01T22:23:43+00:00https://covid19advocacy.org/statement-on-the-act-accelerator-strategic-review/2022-03-01T22:24:10+00:00https://covid19advocacy.org/key-issues-to-be-addressed-in-the-updated-act-a-strategy-october-2021/2022-03-01T22:24:37+00:00https://covid19advocacy.org/call-for-a-community-led-organisation-to-join-the-platform-for-act-a-civil-society-community-representatives-deadline-extended/2022-01-10T19:44:55+00:00https://covid19advocacy.org/hsrc-strategy-update-and-civil-society-participation/2022-03-01T22:25:03+00:00https://covid19advocacy.org/call-for-nominations-act-a-facilitation-council-financial-resource-mobilisation-working-group-deadline-extended-to-10-january-2022/2022-01-10T19:45:06+00:00https://covid19advocacy.org/civil-society-and-community-remarks-at-the-8th-act-a-facilitation-council-meeting-december-2021/2022-03-01T22:25:31+00:00https://covid19advocacy.org/more-transparency-accountability-and-inclusion-needed-in-act-a-letter-to-act-a-leadership-and-brief-from-cs-and-community-representatives/2022-03-01T22:25:56+00:00https://covid19advocacy.org/global-webinar-act-a-strategy/2022-02-15T03:47:38+00:00https://covid19advocacy.org/white-paper-on-community-based-test-treat/2022-09-23T19:47:18+00:00https://covid19advocacy.org/call-for-nominations-community-representative-to-act-a-facilitation-council-financial-resource-mobilisation-working-group/2024-06-02T12:55:52+00:00https://covid19advocacy.org/letter-to-pfizer-from-civil-society-representatives-to-the-act-a-therapeutics-pillar/2022-04-22T01:44:08+00:00https://covid19advocacy.org/covax-civil-society-and-community-representatives-statement-on-the-covax-replenishment-april-2022/2022-06-16T17:00:07+00:00https://covid19advocacy.org/call-for-nominations-act-a-facilitation-tracking-accelerating-progress-working-group/2024-06-02T12:56:37+00:00https://covid19advocacy.org/statement-at-the-who-public-hearings-regarding-a-new-international-instrument-on-pandemic-preparedness-and-response/2022-04-22T01:42:42+00:00https://covid19advocacy.org/call-for-applications-community-based-consultant-to-join-the-platform-for-act-a-civil-society-and-community-representatives/2022-05-03T10:56:42+00:00https://covid19advocacy.org/consultancy-to-conduct-an-evaluation-of-the-platform-for-act-a-civil-society-community-representatives/2022-05-05T10:05:46+00:00https://covid19advocacy.org/second-global-covid-19-summit-12-may-2022/2022-05-11T08:08:00+00:00https://covid19advocacy.org/statement-on-the-act-a-independent-evaluation-may-2022/2022-05-18T11:30:32+00:00https://covid19advocacy.org/platform-for-act-a-civil-society-and-community-representatives-evaluation/2022-06-16T11:25:48+00:00https://covid19advocacy.org/statement-on-world-trade-organizations-12th-ministerial-conference-june-2022/2022-06-22T13:57:05+00:00https://covid19advocacy.org/the-case-for-cso-representation-on-the-financial-intermediary-fund-for-ppr/2022-06-30T08:59:49+00:00https://covid19advocacy.org/call-for-nominations-global-covid-communities-board/2022-07-06T09:13:46+00:00https://covid19advocacy.org/response-from-the-platform-for-act-a-civil-society-community-representatives-to-the-berlin-declaration-biopharmaceutical-industry-vision-for-equitable-access-in-pandemics/2022-07-19T18:33:46+00:00https://covid19advocacy.org/announcement-interim-cso-representatives-to-the-ppr-fif-governing-board/2022-09-08T09:56:37+00:00https://covid19advocacy.org/act-a-tracking-accelerating-progress-working-group-hosted-a-cso-roundtable-september-2022/2022-09-20T11:42:21+00:00https://covid19advocacy.org/acta-key-lessons/2022-10-07T09:16:41+00:00https://covid19advocacy.org/act-a-external-evaluation/2022-10-12T08:02:22+00:00https://covid19advocacy.org/act-a-facilitation-council-meeting-28-october-2022/2022-10-28T13:04:30+00:00https://covid19advocacy.org/call-for-nominations-future-of-global-health-initiatives/2022-11-17T17:49:52+00:00https://covid19advocacy.org/call-for-nominations-tracking-and-monitoring-task-force/2022-11-08T10:57:10+00:00https://covid19advocacy.org/call-for-nominations-pandemic-fund/2023-05-17T17:30:29+00:00https://covid19advocacy.org/countermeasures-platform-meeting-february-2023/2023-03-22T11:25:33+00:00https://covid19advocacy.org/call-for-nominations-pandemic-fund-governance-board-global-north/2023-04-26T09:45:51+00:00https://covid19advocacy.org/2023-hlm-statement/2023-09-11T20:02:45+00:00https://covid19advocacy.org/civil-society-representatives-pandemic-fund-governance-board/2023-05-17T18:05:25+00:00https://covid19advocacy.org/civil-society-and-communities-statement-on-high-level-meeting-proceedings/2023-09-11T20:04:00+00:00https://covid19advocacy.org/analysis-of-inb-bureaus-text-june-2023/2023-09-11T20:34:46+00:00https://covid19advocacy.org/analysis-zero-draft-of-the-pppr-political-declaration/2023-09-11T20:35:14+00:00https://covid19advocacy.org/analysis-rev-2-pppr-political-declaration/2023-09-11T20:35:42+00:00https://covid19advocacy.org/analysis-of-pppr-political-declaration/2023-09-11T20:36:34+00:00https://covid19advocacy.org/civil-society-analysis-proposed-negotiating-text/2023-11-01T08:45:51+00:00